TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25057878

Group type: EXPERIMENTAL
Intervention: Maternal perchlorate levels in the highest 10% of the study population
Number of subjects: 487

Group type: COMPARATOR
Intervention: Maternal levothyroxine therapy
Number of subjects: 487
Study: 22393088

Group type: EXPERIMENTAL
Intervention: Adjuvant radiation therapy (RT)
Number of subjects: 12925
Study: 19715709

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 16529712

Group type: EXPERIMENTAL
Intervention: Diet with fewer eating episodes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet with more frequent eating episodes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 15841764

Group type: EXPERIMENTAL
Intervention: Phytate-reduced MCD and porridge (PR group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Milk-based infant formula and porridge with regular phytate content (IF group)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Commercial MCD and porridge (CC group)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Infants with Hb < 110 g/l at 12 months
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Infants with S-Zn < 10.7 pmol/l at 12 months
Number of subjects: 300
Study: 12508838

Group type: EXPERIMENTAL
Intervention: Tc-99m-DTPA aerosol scintigraphy
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ga-67 scintigraphy
Number of subjects: 26
Study: 9731046

Group type: COMPARATOR
Intervention: Study 03/87
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Study 04/89
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine and mitoxantrone as consolidation in study 04/89
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Patients with t(4;11) and/or MLL-AF-4 rearrangements
Number of subjects: 57

Group type: COMPARATOR
Intervention: Patients with 11q23 abnormalities
Number of subjects: 57
Study: 8858275

Group type: EXPERIMENTAL
Intervention: Mefloquine (250 mg on Days 1, 2, 3, 8, 15, 22, and 29)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mefloquine (250 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alcohol (sustained blood concentration of about 0.35 mg.ml-1)
Number of subjects: 40
Study: 2179111

Group type: EXPERIMENTAL
Intervention: Podophyllin
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Electrodesiccation
Number of subjects: 450
Study: 6986948

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31294473

Group type: EXPERIMENTAL
Intervention: Modifying the prosthesis to allow for better oral hygiene (test group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard treatment without modifying the prosthesis (control group)
Number of subjects: 48
Study: 28321406

Group type: EXPERIMENTAL
Intervention: Theta suppression/beta enhancement protocol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Theta suppression/alpha enhancement protocol
Number of subjects: 60
Study: 25268968

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 162

Group type: COMPARATOR
Intervention: No-contact (control)
Number of subjects: 162
Study: 24708597

Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention (≥5 servings/day vegetables, ≥2 servings/day fruit, ≥8 ½ servings/day grains (mostly wholegrains), 3-4 servings/week lean meat) for 12 weeks
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard dietary intake during pregnancy (control group)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Antioxidant-rich dietary intervention
Number of subjects: 168
Study: 22914806

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (ACT = 250 s)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (full heparin dose, ACT = 420 s)
Number of subjects: 60
Study: 19845769

Group type: EXPERIMENTAL
Intervention: Oxycodone with A118G variant allele
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Oxycodone with C3435T variant allele
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Oxycodone with G2677T/A variant allele
Number of subjects: 33

Group type: COMPARATOR
Intervention: Combined wild-type genotype 3435CC-2677GG
Number of subjects: 33
Study: 16868020

Group type: EXPERIMENTAL
Intervention: 6-min walk test (6MWT)
Number of subjects: 163
Study: 15775730

Group type: EXPERIMENTAL
Intervention: Exercise (weekly)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Coffee drinking
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Age, BMI, caffeine intake, smoking, and exercise adjustments
Number of subjects: 297
Study: 12410322

Group type: EXPERIMENTAL
Intervention: Specific inspiratory muscle training until an increase of more than 20 cm H2O is reached
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham training (Control group)
Number of subjects: 30
Study: 10613346

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (20 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7603812

Group type: EXPERIMENTAL
Intervention: WI79‐9 virus vaccine (10^7.3 plaque‐forming units in three oral doses separated by 2 months)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study: 2262643

Group type: EXPERIMENTAL
Intervention: Ryegrass allergen (incremental doses applied topically to one eye)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ryegrass allergen (higher antigen concentrations)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ryegrass allergen (320,000 BU/ml)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Buffer (applied to the other eye of ryegrass-sensitive patients)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Similar challenge to non-ryegrass-sensitive control subjects
Number of subjects: 11
Study: 31118

Group type: EXPERIMENTAL
Intervention: Heparin + Urokinase (UK)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Urokinase (UK) in PE
Number of subjects: 300
Study: 31100514

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 16–32 mg/kg/d infusion for 6 days
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo infusion for 6 days
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 27198586

Group type: EXPERIMENTAL
Intervention: Expiratory muscle strength training (EMST) at 70% threshold of maximum expiratory pressure, 5 days per week for 4 weeks, 25 breaths per day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo group with resistance-free sham device
Number of subjects: 24
Study: 25188811

Group type: EXPERIMENTAL
Intervention: Case management interventions, nurse visits, assistive technology, educational brochures
Number of subjects: 438
Study: 23134570

Group type: EXPERIMENTAL
Intervention: 2009 pandemic (H1N1) vaccine containing 7.5 μg haemagglutinin (HA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2009 pandemic (H1N1) vaccine containing 15 μg haemagglutinin (HA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Seasonal influenza vaccine
Number of subjects: 0
Study: 20473893

Group type: EXPERIMENTAL
Intervention: Carriers of the rare T allele of the VDR gene (rs2228570)
Number of subjects: 5299

Group type: EXPERIMENTAL
Intervention: Carriers of the rare T allele of the VDR gene (rs2228570) among younger women (< 50 years)
Number of subjects: 5299

Group type: EXPERIMENTAL
Intervention: Carriers of the rare T allele of the VDR gene (rs2228570) among younger women (< 50 years) after excluding Hawaii data
Number of subjects: 5299
Study: 19171723

Group type: EXPERIMENTAL
Intervention: Simulated case‐based physician learning intervention (group B)
Number of subjects: 2020

Group type: EXPERIMENTAL
Intervention: Simulated case‐based learning intervention with physician opinion leader feedback (group C)
Number of subjects: 2020

Group type: COMPARATOR
Intervention: No intervention (group A)
Number of subjects: 2020
Study: 16845146

Group type: COMPARATOR
Intervention: Statins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lipid-lowering therapy
Number of subjects: 0
Study: 15596746

Group type: EXPERIMENTAL
Intervention: Exercise group (strength and aerobic training for 6 months)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 95
Study: 11305513

Group type: COMPARATOR
Intervention: Tetanus toxoid vaccine (1 ml, 6 Lf units)
Number of subjects: 22
Study: 9013434

Group type: EXPERIMENTAL
Intervention: NCEP Step I diet
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: NCEP Step II diet
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: NCEP Step I and II diets
Number of subjects: 409
Study: 9275136

Group type: EXPERIMENTAL
Intervention: Heated egg white
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Heated and ovomucoid-depleted egg white
Number of subjects: 38

Group type: COMPARATOR
Intervention: Freeze-dried egg white
Number of subjects: 38

Group type: COMPARATOR
Intervention: Other proteins in egg white
Number of subjects: 38
Study: 2719236

Group type: EXPERIMENTAL
Intervention: Lumbar epidural morphine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Thoracic epidural morphine
Number of subjects: 37
Study: 819598

Group type: EXPERIMENTAL
Intervention: Adenine arabinoside
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Trifluorothymidine
Number of subjects: 102
Study: 31402008

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 3412

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3412
Study: 26886047

Group type: EXPERIMENTAL
Intervention: Modified dynamic orthosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional static orthosis
Number of subjects: 0
Study: 26507494

Group type: EXPERIMENTAL
Intervention: Acupoint stimulation + dexamethasone (Group Acu)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Tropisetron + dexamethasone (Group Trp)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Dexamethasone alone (Group Dxm)
Number of subjects: 157
Study: 23855415

Group type: EXPERIMENTAL
Intervention: Program SI! (intervention schools)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal curriculum (control schools)
Number of subjects: 24
Study: 19081697

Group type: EXPERIMENTAL
Intervention: MDI/spacer combination
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nebulizer
Number of subjects: 60
Study: 18842256

Group type: EXPERIMENTAL
Intervention: Varenicline (x 21 days)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (x 21 days)
Number of subjects: 67
Study: 16409529

Group type: EXPERIMENTAL
Intervention: 30 ml x kg(‐1) x h(‐1) of lactated Ringer's solution (superhydration group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 10 ml x kg(‐1) x h(‐1) of lactated Ringer's solution (control group)
Number of subjects: 100
Study: 15282232

Group type: EXPERIMENTAL
Intervention: Tailored professional intervention including clinical practice guideline, educational outreach visit, and postal reminder.
Number of subjects: 1503

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 1503
Study: 11702916

Group type: EXPERIMENTAL
Intervention: 10 m shuttle walk test (SWT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 6 minute walk test (6WT)
Number of subjects: 0
Study: 9135528

Group type: EXPERIMENTAL
Intervention: Isoprenaline (2.5 micrograms/kg/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Propranolol (25 micrograms/kg/min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 16
Study: 8109230

Group type: EXPERIMENTAL
Intervention: Atropine 0.01 mg/kg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Atropine 0.02 mg/kg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Halothane anesthesia (control)
Number of subjects: 34
Study: 3292596

Group type: EXPERIMENTAL
Intervention: Prostacyclin (epoprostenol) infused intravenously at a dose of up to 5 ng/kg/min for 72 hours with a tapering off period for the last 12 hours.
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Prostacyclin (epoprostenol) in open-label fashion.
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo infused intravenously for the same duration and dosage as prostacyclin.
Number of subjects: 156
Study: 30848576

Group type: EXPERIMENTAL
Intervention: M2000 (β-D-Mannuronic Acid), 500 mg two times a day for 6-8 weeks
Number of subjects: 24
Study: 28349228

Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 36
Study: 26250771

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol at 80 μg/day
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 24703369

Group type: EXPERIMENTAL
Intervention: Multiple complex plaques
Number of subjects: 3137

Group type: COMPARATOR
Intervention: Single complex plaque
Number of subjects: 3137
Study: 22000795

Group type: EXPERIMENTAL
Intervention: 1-injection group (20 mL of 0.75% bupivacaine and 10 mL 98% alcohol)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2-injection group (20 mL of 0.75% bupivacaine and 10 mL 98% alcohol)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 50
Study: 18447921

Group type: EXPERIMENTAL
Intervention: Intensive care plus total body cooling for 72 hours
Number of subjects: 325

Group type: COMPARATOR
Intervention: Intensive care without cooling
Number of subjects: 325
Study: 16140461

Group type: EXPERIMENTAL
Intervention: Male-to-female transsexuals (MFT)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Female-to-male transsexuals (FMT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control males
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control females
Number of subjects: 63
Study: 12919397

Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 1
Study: 10740548

Group type: EXPERIMENTAL
Intervention: Bupivacaine 5 mg ml-1 in 0.9% glucose solution
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bupivacaine 5 mg ml-1 in 8% glucose solution
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 100
Study: 8824472

Group type: EXPERIMENTAL
Intervention: Combined pancreas-kidney transplantation (PKT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pancreas-kidney transplantation with pancreas failure (PKT-P)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PKT
Number of subjects: 22
Study: 1577940

Group type: EXPERIMENTAL
Intervention: Incubation for 24 h in T6 medium with 50% follicular fluid (v/v)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Incubation for 24 h in T6 medium followed by electroporation and incubation for a few hours in T6 medium with 3.5 mM pentoxifylline
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Subzonal insemination of oocytes
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Subzonal insemination of fertilized oocytes
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Embryo replacement in cycles
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Prenatal diagnosis by amniocentesis
Number of subjects: 43
Study: 3156501

Group type: EXPERIMENTAL
Intervention: Laparoscopic aspiration under general anesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ultrasonically guided aspiration with local anesthesia
Number of subjects: 20
Study: 31546768

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet intervention (active intervention) for 6 months
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Self-sustained continuation phase (SSP) of the intervention
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intake of olive oil
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Choosing olive oil as a type of fat
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intake of red and processed meats
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Overall mMDS
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Nutrient intake from FFQ
Number of subjects: 48
Study: 30282688

Group type: EXPERIMENTAL
Intervention: LoDED strategy (using a single high-sensitivity troponin blood test with an undetectable cut-off and ECG findings)
Number of subjects: 594

Group type: COMPARATOR
Intervention: Usual care (existing rule-out strategies using serial high-sensitivity troponin testing)
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: LoDED strategy
Number of subjects: 594

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 594
Study: 27348903

Group type: EXPERIMENTAL
Intervention: YANG's pricking‐cupping therapy
Number of subjects: 171

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 171
Study: 25308231

Group type: EXPERIMENTAL
Intervention: VK1 solution
Number of subjects: 144

Group type: COMPARATOR
Intervention: VK1 tablets
Number of subjects: 144
Study: 22762168

Group type: EXPERIMENTAL
Intervention: Rebonding of the fractured tooth fragment (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ceramic veneers (Group C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intact teeth (Group A)
Number of subjects: 30
Study: 20483024

Group type: EXPERIMENTAL
Intervention: Minimally invasive treatment group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Medical treatment group
Number of subjects: 27
Study: 18587731

Group type: EXPERIMENTAL
Intervention: Once-weekly intravenous epoetin alfa
Number of subjects: 289

Group type: COMPARATOR
Intervention: Conventional dosing of intravenous epoetin alfa or darbepoetin
Number of subjects: 289
Study: 15878216

Group type: EXPERIMENTAL
Intervention: Molecular Adsorbents Recirculating System (MARS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Haemofiltration
Number of subjects: 11
Study: 11835638

Group type: EXPERIMENTAL
Intervention: Aspirin monotherapy after Carbostent implantation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Combined ticlopidine and aspirin (future comparison group)
Number of subjects: 110
Study: 10634963

Group type: EXPERIMENTAL
Intervention: Glucagon infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6
Study: 7770254

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (less than 200 mg/day)
Number of subjects: 11
Study: 1975150

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.1 mg/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Pancuronium (0.1 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 16
Study: 7132652

Group type: EXPERIMENTAL
Intervention: Ergometer A
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ergometer B
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ergometer C
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ergometer D
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Physiological data
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ergometer A, C, and D
Number of subjects: 10
Study: 30739560

Group type: EXPERIMENTAL
Intervention: Collum Femoris Preserving (CFP) stem
Number of subjects: 83

Group type: COMPARATOR
Intervention: Corail stem
Number of subjects: 83
Study: 27550292

Group type: EXPERIMENTAL
Intervention: Slow maxillary expansion (SME)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 46
Study: 26682997

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (Ω3)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Individual family psychoeducational psychotherapy (IF-PEP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: COMPARATOR
Intervention: Active Monitoring (AM)
Number of subjects: 23
Study: 23512912

Group type: EXPERIMENTAL
Intervention: Metreleptin (physiological doses)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (post-surgery weight loss)
Number of subjects: 23
Study: 21243592

Group type: EXPERIMENTAL
Intervention: Minimally invasive approach (MIS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Conventional approach (KONV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (VG)
Number of subjects: 48
Study: 19411799

Group type: EXPERIMENTAL
Intervention: Breast-feeding Empowerment Program (EG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 0
Study: 17511770

Group type: EXPERIMENTAL
Intervention: Baclofen 10 mg three times daily for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 60
Study: 15271125

Group type: EXPERIMENTAL
Intervention: Anticoagulants
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Cardiovascular drugs
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Hormones
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Nonopioid analgesics (predominantly NSAIDs and acetaminophen)
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Anti-seizure medications
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Charlson Comorbidity Index
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Number of scheduled medications
Number of subjects: 30397

Group type: EXPERIMENTAL
Intervention: Being female and aged 80 and older
Number of subjects: 30397
Study: 11878715

Group type: EXPERIMENTAL
Intervention: Acetosalicylic acid (ASA)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combination of calcium channel blockers and ASA
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Diuretics and ASA
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (random controls)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Dental infections rating scales
Number of subjects: 51